AtheroNova Inc. announced that Erik SG Stroes, MD, Chair and Professor at the Department of Vascular Medicine at the Academic Medical Center (AMC), Amsterdam has joined the company as a member of the Clinical Advisory Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -26.67% |
2016 | AtheroNova Operations, Inc. Bankruptcy Case Dismissed | CI |
2015 | First Motion for Exclusivity Period Extension Approved For AtheroNova Operations, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-26.67% | 9.69K | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- AHROQ Stock
- News AtheroNova Inc.
- AtheroNova Inc. Appoints Dr. Erik Stroes to its Clinical Advisory Board